2016 Press Releases

Keyword Search
 

November 14, 2016

Protagonist Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update read more

October 13, 2016

Protagonist Therapeutics to Present Phase 1 Clinical and Preclinical Data on PTG-100 at UEG Week, Vienna read more

August 10, 2016

Protagonist Therapeutics Announces Pricing of Initial Public Offering read more

July 28, 2016

Protagonist Therapeutics Receives SBIR Funding for the Development of Injectable Hepcidin Mimetics for Treatment of Iron Overload Disorders read more

July 08, 2016

William D. Waddill, Calithera CFO, Elected to Protagonist Therapeutics Board read more

May 17, 2016

Protagonist Therapeutics to Present New Data for PTG-100 and PTG-200 at Digestive Disease Week 2016 read more

February 17, 2016

Protagonist Therapeutics Names Thomas P. O'Neil Chief Financial Officer read more

January 08, 2016

Protagonist Therapeutics Initiates Phase 1 Study with Oral Peptide PTG-100 read more